Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared on LinkedIn about his recent article, adding:
”Happy to share a new review article on thrombin generation testing I wrote and recently accepted by Clinics in Laboratory Medicine for a special edition.
The article describes a assay I am very passionate about which has the potential to give clinicians better information about patients’ global risk of bleeding or thrombosis.
The assay is not FDA cleared but available for research in the US and Canada.
It is being used in clinical settings internationally, though in limited volume.
Hopefully usage will increase over time especially if there’s a successful FDA submission at some point.
Thank you to the editors for inviting me to contribute.”
Title: Thrombin Generation Assay: Ready for Prime Time
Authors: Paul Riley
Read the Full Article on Clinics in Laboratory Medicine

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines